Education
About Us
Working with TipRanks
Follow Us
Craneware Plc (GB:CRW)
LSE:CRW
CRW Stock Chart & Stats
2230.00p
-80.00p(-3.72%)
At close: 4:00 PM EST
2230.00p
-80.00p(-3.72%)
Day’s Range― - ―
52-Week Range1,385.00p - 2,644.00p
Previous CloseN/A
Volume2.39K
Average Volume (3M)71.71K
Market Cap
£502.62M
Enterprise Value662.29M
Total Cash (Recent Filing)£55.92M
Total Debt (Recent Filing)£31.65M
Price to Earnings (P/E)32.9
Beta0.70
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)0.27
Shares Outstanding35,508,820
10 Day Avg. Volume64,377
30 Day Avg. Volume71,707
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)3.07
Price to Sales (P/S)5.04
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£2,875.00Price Target Upside28.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet And Low LeverageA very low debt-to-equity ratio (0.09) gives Craneware durable financial flexibility. This conservative capital structure supports investment, M&A, and shareholder actions without stress from interest burden, reducing refinancing risk and preserving optionality over the next 2–6 months.
Very High Gross MarginsGross margins above 85% reflect scalable software economics and pricing power in healthcare revenue-cycle tools. High product-level profitability provides a durable buffer for reinvestment in R&D or sales while supporting sustainable operating margins even if sales mix or service costs shift.
Recurring SaaS-driven Revenue ModelA subscription-heavy revenue mix yields predictable, recurring cash flows and higher customer lifetime value. This structural business model supports steady revenue visibility, easier customer retention and cross-sell, and more durable top-line resilience over multiple quarters.
Bears Say
Free Cash Flow Growth Has DeclinedA 13.4% decline in free cash flow growth indicates weakening conversion of earnings into discretionary cash. If persistent, this reduces the company's ability to fund buybacks, dividends, or strategic investments without drawing on reserves, constraining long-term financial flexibility.
Relatively Low Return On EquityLow ROE signals that the company may not be efficiently converting equity into profits. Over time this can limit shareholder returns and may pressure management to pursue lower-return growth or capital actions, weakening the long-term attractiveness versus higher-ROE peers.
Modest Recent Revenue GrowthRevenue growth of 3.8% in the latest year is modest for a SaaS-oriented healthcare software provider. Slower top-line expansion can limit operating leverage and long-term market share gains, making it harder to scale R&D and sales investments while competing with faster-growing peers.
Craneware News
CRW FAQ
What was Craneware Plc’s price range in the past 12 months?
Craneware Plc lowest share price was 1385.00p and its highest was 2644.00p in the past 12 months.
What is Craneware Plc’s market cap?
Craneware Plc’s market cap is £502.62M.
When is Craneware Plc’s upcoming earnings report date?
Craneware Plc’s upcoming earnings report date is Mar 02, 2026 which is in 7 days.
How were Craneware Plc’s earnings last quarter?
Craneware Plc released its earnings results on Sep 15, 2025. The company reported 0.273p earnings per share for the quarter, beating the consensus estimate of N/A by 0.273p.
Is Craneware Plc overvalued?
According to Wall Street analysts Craneware Plc’s price is currently Undervalued.
Does Craneware Plc pay dividends?
Craneware Plc pays a Semiannually dividend of 18.5p which represents an annual dividend yield of 1.66%. See more information on Craneware Plc dividends here
What is Craneware Plc’s EPS estimate?
Craneware Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Craneware Plc have?
Craneware Plc has 35,508,820 shares outstanding.
What happened to Craneware Plc’s price movement after its last earnings report?
Craneware Plc reported an EPS of 0.273p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.643%.
Which hedge fund is a major shareholder of Craneware Plc?
Currently, no hedge funds are holding shares in GB:CRW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Craneware Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.04%
12-Months-Change
Fundamentals
Return on Equity
6.00%
Trailing 12-Months
Asset Growth
-6.53%
Trailing 12-Months
Company Description
Craneware Plc
Craneware (CRW) is a leading provider of revenue integrity solutions for the healthcare sector, primarily focusing on optimizing the financial performance of healthcare providers in the United States. The company specializes in software solutions that help hospitals and health systems manage their revenue cycles, ensuring accurate billing and compliance with complex regulations. Core products include Chargemaster Toolkit, Revenue Cycle Analytics, and other related services that streamline operations and enhance financial outcomes for healthcare organizations.
CRW Stock 12 Month Forecast
Average Price Target
2,875.00p
▲(28.92% Upside)
Technical Analysis
Options Prices
Currently, No data available
---